Ketamine and Spravato therapy are both used to help people with treatment-resistant depression and certain other mental health conditions, but they are not the same treatment. The biggest differences involve the medication itself, how it is given, FDA approval, insurance coverage, and the conditions for which each treatment is prescribed.
Imagine trying multiple antidepressants, attending therapy sessions, and making healthy lifestyle changes, yet still feeling trapped by depression. This experience is more common than many people realize, leading healthcare providers to explore innovative treatments that work differently from traditional medications. Among the most talked-about options today are ketamine therapy and Spravato therapy, but understanding how they differ is essential before deciding which approach may be right for you.
Understanding Ketamine Therapy
Ketamine is a medication that has been used safely as an anesthetic for decades. In recent years, researchers discovered that low doses of ketamine may rapidly reduce symptoms of depression, especially in people who have not responded to conventional antidepressants.
Unlike standard antidepressants that often take several weeks to become effective, ketamine may begin improving symptoms within hours or days for some patients. This rapid response has made it an important option for individuals experiencing severe depression or suicidal thoughts.
Ketamine therapy is typically administered through:
- Intravenous (IV) infusion
- Intramuscular (IM) injection
- Oral lozenges (in selected cases)
- Sublingual formulations
Treatment is always supervised by qualified healthcare professionals who monitor the patient’s physical and emotional response throughout the session.
Many treatment plans also include Bipolar disorder supportive therapy to help patients manage mood changes, develop coping skills, and maintain long-term emotional stability after ketamine sessions.
What Is Spravato Therapy?
Spravato is the brand name for esketamine, a medication derived from ketamine. While ketamine contains two mirror-image molecules, Spravato contains only one specific form called esketamine.
Spravato received FDA approval specifically for:
- Treatment-resistant depression
- Major depressive disorder with acute suicidal thoughts or behaviors (alongside oral antidepressants)
Unlike traditional ketamine therapy, Spravato is administered as a nasal spray in a certified healthcare facility. Patients remain under observation for approximately two hours after treatment to ensure safety and monitor possible side effects.
Many providers combine Spravato with psychotherapy and Mindfulness yoga practices to improve emotional regulation and encourage lasting recovery.
Ketamine vs. Spravato: The Main Differences
FDA Approval
One of the most significant differences is regulatory approval.
Ketamine is FDA-approved as an anesthetic, while its use for depression is considered “off-label.” Physicians may legally prescribe medications off-label when supported by scientific evidence.
Spravato, on the other hand, is FDA-approved specifically for certain forms of depression, giving healthcare providers a standardized treatment protocol.
Medication Composition
Although closely related, ketamine and Spravato are chemically different.
Ketamine contains:
- R-ketamine
- S-ketamine
Spravato contains only:
- S-ketamine (esketamine)
Researchers continue studying whether one formulation offers advantages over the other for specific patients.
How They Are Administered
Ketamine therapy commonly uses IV infusions or injections administered in specialized clinics.
Spravato is delivered through a nasal spray under direct medical supervision.
Both treatments require monitoring because temporary side effects such as dizziness, increased blood pressure, or mild dissociation may occur.
Patients frequently benefit from Bipolar disorder supportive therapy, which helps them process emotional experiences that arise during treatment sessions.
Insurance Coverage
Insurance coverage often differs considerably.
Because Spravato is FDA-approved for depression, many insurance plans provide partial or full coverage if eligibility requirements are met.
Ketamine infusions, however, are often considered off-label treatment and may require out-of-pocket payment, depending on the insurance provider and location.
Before beginning either treatment, patients should verify benefits with their insurance company and discuss expected costs with the clinic.
Effectiveness
Both treatments have shown promising results in clinical studies.
Many patients experience:
- Reduced depressive symptoms
- Improved mood
- Better daily functioning
- Increased hope and motivation
Response rates vary from person to person, making individualized treatment planning extremely important.
Healthcare providers often recommend combining medication with psychotherapy, Mindfulness yoga, healthy sleep habits, and regular follow-up appointments for the best long-term outcomes.
Who May Benefit From Ketamine Therapy?
Ketamine therapy may be appropriate for individuals who have:
- Treatment-resistant depression
- Severe depression
- Chronic suicidal thoughts
- Certain anxiety disorders
- Some chronic pain conditions
It may also be considered in carefully selected patients with bipolar depression, though careful psychiatric evaluation is essential.
Many comprehensive treatment programs include Bipolar disorder supportive therapy alongside medication to help patients recognize mood patterns, strengthen coping strategies, and reduce relapse risk.
Who May Benefit From Spravato?
Spravato is generally recommended for adults diagnosed with treatment-resistant depression or major depressive disorder with suicidal thoughts when combined with an oral antidepressant.
Because the treatment follows FDA-approved guidelines, patients receive standardized dosing schedules and monitoring procedures.
Some clinics also encourage Mindfulness yoga between appointments to reduce stress, improve sleep quality, and support overall mental wellness.
Side Effects and Safety
Both treatments have similar potential side effects, including:
- Dizziness
- Sleepiness
- Nausea
- Temporary increase in blood pressure
- Dissociation
- Headache
These effects are usually temporary and resolve within a few hours.
Patients should not drive after treatment and should arrange transportation home following each session.
Clinics also emphasize lifestyle support through counseling, Mindfulness yoga, balanced nutrition, and healthy routines to maximize treatment success.
The Role of Therapy Alongside Medication
Medication alone is rarely the complete answer for long-term mental wellness.
Many psychiatrists recommend combining ketamine or Spravato with evidence-based psychotherapy to help patients:
- Understand emotional triggers
- Develop healthier coping mechanisms
- Improve relationships
- Build resilience
- Prevent relapse
For individuals living with bipolar disorder, Bipolar disorder supportive therapy plays an especially valuable role by helping patients maintain mood stability, recognize early warning signs, and strengthen daily routines.
Likewise, Mindfulness yoga offers gentle breathing exercises, movement, and meditation that may reduce stress and complement professional mental health treatment.
Choosing Between Ketamine and Spravato
The right option depends on several individual factors, including:
Your Diagnosis
Different conditions may respond differently, making an accurate psychiatric evaluation essential.
Previous Treatment History
Healthcare providers review medications, therapy history, and previous responses before recommending either treatment.
Insurance and Cost
Financial considerations often influence treatment decisions because coverage differs significantly between ketamine and Spravato.
Medical History
Existing health conditions, medications, and risk factors may affect treatment eligibility.
Personal Preferences
Some patients prefer IV infusions, while others feel more comfortable using a nasal spray.
Regardless of the choice, incorporating Bipolar disorder supportive therapy and Mindfulness yoga into a personalized treatment plan may improve emotional resilience and support long-term recovery.
Conclusion
Ketamine and Spravato share similar goals but differ in their formulation, FDA approval, method of administration, and insurance coverage. Both treatments offer hope for individuals who have not found relief through traditional antidepressants, especially when combined with psychotherapy, healthy lifestyle habits, Bipolar disorder supportive therapy, and Mindfulness yoga as part of a comprehensive mental health plan. If you’re exploring advanced treatment options, speaking with experienced professionals at Massachusetts Mind Center can help determine which approach best fits your individual needs.
FAQs
1. Is Spravato the same as ketamine?
No. Spravato contains esketamine, while ketamine contains both R-ketamine and S-ketamine.
2. Which treatment works faster?
Both may produce improvements much faster than traditional antidepressants, although individual responses vary.
3. Is ketamine therapy FDA-approved for depression?
No. Ketamine is used off-label for depression, while Spravato has FDA approval for specific depressive disorders.
4. Can therapy improve treatment outcomes?
Yes. Combining medication with psychotherapy, healthy habits, and supportive approaches often leads to better long-term results.
5. Are ketamine and Spravato safe?
When administered by qualified medical professionals under proper supervision, both treatments have established safety protocols and monitoring procedures.
